TickerFactsScreenerDevelopers

ALNYLAM PHARMACEUTICALS, INC. (ALNY) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2008: $65.49M2009: -$72.14M2010: -$84.34M2011: -$87.07M2012: -$115.61M2013: -$68.66M2016: -$307.70M2017: -$382.79M2018: -$562.62M2019: -$278.43M2020: -$614.96M2021: -$641.69M2022: -$541.27M2023: $104.16M2024: -$8.31M2025: $524.08M$524.08M
2008Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$524.08M+6405.1%
2024-$8.31M-108.0%
2023$104.16M+119.2%
2022-$541.27M+15.6%
2021-$641.69M-4.3%
2020-$614.96M-120.9%
2019-$278.43M+50.5%
2018-$562.62M-47.0%
2017-$382.79M-24.4%
2016-$307.70M—
2013-$68.66M+40.6%
2012-$115.61M-32.8%
2011-$87.07M-3.2%
2010-$84.34M-16.9%
2009-$72.14M-210.2%
2008$65.49M—